Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (Bilen2018e), dental plaque and umbilical drainage
DNA G+C(%): 45-46
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: S(MIC50): 0.5, MIC90: 2, RNG: (0.06-8)
penicillin_G: Res
imipenem: S(MIC50): 0.06, MIC90: 0.25, RNG: (0.03-1)
|
|
kanamycin: Res
|
erythromycin: S(MIC50): 1, MIC90: 2, RNG: (0.125-8)
|
ciprofloxacin: Var(MIC50): 1, MIC90: 16, RNG: (0.25-32)
gatifloxacin: S(MIC50): 0.25, MIC90: 2, RNG: (0.125-4)
trovafloxacin: S(MIC50): 0.5, MIC90: 1, RNG: (0.125-2)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
vancomycin: Res
|
bacitracin: Res
rifampicin: Sens
|
metronidazole: S(MIC50): 0.25, MIC90: 1, RNG: (0.125-1)
|
clindamycin: S(MIC50): 0.03, MIC90: 0.5, RNG: (0.03-4)
colistin: Res
|